Metraipolis › archive › dc_3cafad040c44
Cefepime Combined with Late-Generation β-Lactamase Inhibitors: Mechanisms of Action, In Vitro Activity, PK/PD Characteristics, Clinical Evidence and… — Europe PMC PMID:41892425
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41892425
- DOI
- 10.3390/antibiotics15030263
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T03:55:47.776Z
- SHA-256 of the archived text
9b8df78ceacf91e2f920526ce6e4f973304a7362ccfe2ae2b46728c107b2f56a- Stable URL of this page
https://metraipolis.com/documento/dc_3cafad040c44
How to cite
Cefepime Combined with Late-Generation β-Lactamase Inhibitors: Mechanisms of Action, In Vitro Activity, PK/PD Characteristics, Clinical Evidence and… — Europe PMC PMID:41892425 — Europe PMC (en), https://europepmc.org/article/MED/41892425 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3cafad040c44 (Metraipolis archive dc_3cafad040c44, sha256 9b8df78ceacf91e2f920526ce6e4f973304a7362ccfe2ae2b46728c107b2f56a)
BibTeX
@misc{dc3cafad040c44,
title = {Cefepime Combined with Late-Generation β-Lactamase Inhibitors: Mechanisms of Action, In Vitro Activity, PK/PD Characteristics, Clinical Evidence and… — Europe PMC PMID:41892425},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41892425},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3cafad040c44; sha256 9b8df78ceacf91e2f920526ce6e4f973304a7362ccfe2ae2b46728c107b2f56a},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41892425. Agents can read the archived copy with the MCP tool read_document.